Tremfya was administered subcutaneously for both induction and maintenance, inducing a clinical response in 65% of moderate to severe UC patients.

Psoriasis was less likely to progress to psoriatic arthritis (PsA) among patients treated with interleukin-17 (IL-17) or ...

UCB’s Bimzelx is firmly on physicians’ radars, with Spherix Global Insights finding that awareness of the drug was tracking ...

Get an expert’s answers to common questions about how physical therapy can help with psoriatic arthritis, and learn how to get started. Living with psoriatic arthritis can mean chronic joint ...

This is called psoriatic arthritis, and it can lead to pain in your knees and other joints. Psoriasis is an autoimmune skin condition that causes your skin cells to build up and form dry ...

The majority of people with psoriatic arthritis first experience skin symptoms. One of the most common is a rash with thick, discolored skin covered with flaky, lighter-colored patches.

Rheumatoid arthritis is an autoimmune disease that is characterized by inflammation of the joints and the subsequent destruction of cartilage and erosion of the bone. Patients with rheumatoid ...

Psoriatic Arthritis, Crohn's Disease, and Ulcerative Colitis for Skyrizi, and Rheumatoid Arthritis, Psoriatic Arthritis, Atopic Dermatitis, Ulcerative Colitis, Crohn's Disease, Ankylosing ...

The decline was offset by sales of its newer arthritis drugs Skyrizi, which soared by 57% to $3.78 billion, and Rinvoq, which logged a 46% gain to $1.83 billion. Chief Executive Robert Michael ...

Today, a brief rundown of news involving Novartis and AbbVie, as well as updates from Biogen, Merck & Co. and Sanofi that you may have missed. Expected readouts in diabetes, cancer and depression ...